Amgen’s Enbrel heads ICER list of unjustified US price risesUS cost effectiveness watchdog ICER found 10 examples of substantial price rises for top-selling medicines in 2019, and Share XAmgen’s Enbrel heads ICER list of unjustified US price riseshttps://pharmaphorum.com/news/icer-lists-top-unjustified-drug-price-rises-headed-by-amgens-enbrel/
Valeant could sell gastro drug unit to TakedaValeant may sell Salix and other units to pay off debts. Share XValeant could sell gastro drug unit to Takedahttps://pharmaphorum.com/news/valeant-could-sell-gastro-drug-unit-to-takeda/